Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
Trial record 2 of 6 for:    H1N1 AND asthma

Epidemiology and Clinical Presentation of H1N1 Infection in Children in Geneva

This study has been completed.
Information provided by (Responsible Party):
Klara M. Pósfay Barbe, University Hospital, Geneva Identifier:
First received: November 30, 2009
Last updated: December 10, 2012
Last verified: December 2012
This study aims to identify clinical symptoms and outcomes, as well as response to anti-viral treatment in children living in Geneva, with influenza A/ H1N1 infection during the current pandemic.

Neuromuscular Diseases

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Evaluation of a New Virus(Influenza A H1N1/09) in Children: Epidemiology, Clinical Presentation and Outcome, and Response to Treatment

Resource links provided by NLM:

Further study details as provided by University Hospital, Geneva:

Primary Outcome Measures:
  • ABCB1 polymorphisms [ Time Frame: 6 months ] [ Designated as safety issue: No ]
    ABCB1 gene polymorphisms and neuropsychiatric adverse events in oseltamivir-treated children during influenza H1N1/09 pandemia

Biospecimen Retention:   Samples With DNA
Nasal swab; DNA for genetic polymorphisms (Response to oseltamivir)

Enrollment: 200
Study Start Date: October 2009
Study Completion Date: July 2012
Primary Completion Date: February 2010 (Final data collection date for primary outcome measure)

Ages Eligible for Study:   up to 16 Years   (Child)
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Children seen at the emergency ward

Inclusion Criteria:

  • suspicion of H1N1 infection

Exclusion Criteria:

  • Not available for a 30 days follow-up
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01022931

Children's Hospital of Geneva, HUG
Geneva, GE, Switzerland, 1211
Sponsors and Collaborators
University Hospital, Geneva
Principal Investigator: Klara M Posfay-Barbe, MD, MS University Hospitals of Geneva
  More Information

Responsible Party: Klara M. Pósfay Barbe, Head of Pediatric Infectious Diseases, University Hospital, Geneva Identifier: NCT01022931     History of Changes
Other Study ID Numbers: H1N1epidemiology 
Study First Received: November 30, 2009
Last Updated: December 10, 2012
Health Authority: Switzerland: Laws and standards

Keywords provided by University Hospital, Geneva:
Influenza A H1N1

Additional relevant MeSH terms:
Neuromuscular Diseases
Nervous System Diseases processed this record on October 21, 2016